Biotechnology in Asia-Pacific

Biotechnology in Asia-Pacific

Summary

Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Asia-Pacific biotechnology industry had total revenues of $99.5bn in 2018, representing a compound annual growth rate (CAGR) of 6.3% between 2014 and 2018.
- The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of $53.8bn, equivalent to 54.1% of the industry's overall value.
- The industry is driven mainly by Japan and China, which accounted for 37.6% and 20.9% of its total value in 2018.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific biotechnology market by value in 2018?
- What will be the size of the Asia-Pacific biotechnology market in 2023?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players in the market?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. Have there been any new product launches in recent years?
7.6. What are the weaknesses of leading players?
8 Company Profiles
8.1. Shanghai Kehua Bio-engineering Co Ltd
8.2. Astellas Pharma China Inc
8.3. Novo Nordisk Pharmatech A/S
8.4. Takeda Pharmaceutical Company Limited
9 Appendix
9.1. Methodology
9.2. About MarketLine